Drug
MSC-AFP
MSC-AFP is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
5
100%
Phase Distribution
5
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
5(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 15 (100.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
Pediatric MSC-AFP Sub-study for Crohn's Fistula
NCT03449069
completedphase_1
Stem Cell Coated Fistula Plug in Patients With Crohn's RVF
NCT03220243
completedphase_1
Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas
NCT03209700
completedphase_1
Stem Cell Fistula Plug in Perianal Crohn's Disease
NCT01915927
completedphase_1
Stem Cell Fistula Plug in Cryptoglandular Perianal Fistulas (MSC-AFP)
NCT02589119
Clinical Trials (5)
Showing 5 of 5 trials
NCT03449069Phase 1
Pediatric MSC-AFP Sub-study for Crohn's Fistula
NCT03220243Phase 1
Stem Cell Coated Fistula Plug in Patients With Crohn's RVF
NCT03209700Phase 1
Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas
NCT01915927Phase 1
Stem Cell Fistula Plug in Perianal Crohn's Disease
NCT02589119Phase 1
Stem Cell Fistula Plug in Cryptoglandular Perianal Fistulas (MSC-AFP)
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5